Figure 3.
Figure 3. The RATIFY phase 3 trial in patients with FLT3-mutated AML involved a global collaboration framework across academia, industry, and government.

The RATIFY phase 3 trial in patients with FLT3-mutated AML involved a global collaboration framework across academia, industry, and government.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal